RMD
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

ResMed Inc. is a digital health company that designs and manufactures cloud-connected medical devices and software solutions for sleep and breathing health disorders. The company operates in two segments: Sleep and Breathing Health, which includes CPAP systems for obstructive sleep apnea, ventilators, diagnostic products, and mask systems; and Residential Care Software, which provides care management platforms for senior living and home health providers. ResMed serves patients, healthcare professionals, and residential care facilities globally. Key subsidiaries and acquired businesses include Noctrix Health for restless legs syndrome treatment, VirtuOx for independent diagnostic testing, Brightree for durable medical equipment workflow automation, and MEDIFOX DAN for care management in Germany. The company was formed in 1989 and commercialized the first successful non-invasive CPAP treatment for obstructive sleep apnea.

Summarised from the company's own disclosures, fiscal year ended Aug 2026

Industry Medical Devices Homepage resmed.com
Sector Healthcare IR page —
Tags
sleep apnea, cpap therapy, respiratory care, home healthcare, digital health, cloud-connected devices, residential care software, diagnostic testing, chronic disease management, medical devices, AirFit 20 Series, Noctrix Health, VirtuOx, Brightree, MEDIFOX DAN, MatrixCare, Healthcare First, Citus
Press page —

Metrics

Valuation  
Market cap $ 33.331B
Market cap (USD) $ 33.331B
P/E 21.58
PEG 1.12
P/BV 5.60
P/S 5.81
P/OCF 18.82
P/FCF 20.72
Dividend yield 1.0%
Turnover / mcap —
Returns  
ROE 24.3%
ROI 21.8%
ROIC 21.4%
Profit margin 26.9%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 19.3%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 4.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 53
Quality score 47.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 5.653B 5.146B 4.685B 4.223B 3.578B 3.197B 2.957B 2.607B 2.34B 2.067B 1.839B 1.679B 1.555B 1.514B 1.369B 1.243B 1.092B 920.735M 835.397M 716.332M 606.996M 425.505M 339.338M 273.57M 204.076M 155.156M 115.615M
Net profit 1.523B 1.401B 1.021B 897.556M 779.437M 474.505M 621.674M 404.592M 315.588M 342.284M 352.409M 352.886M 345.273M 307.133M 254.85M 226.986M 190.085M 146.448M 110.303M 66.302M 88.211M 64.785M 57.284M 45.729M 37.506M 11.63M 22.226M
Free cash flow 1.65B 1.662B 1.302B 573.627M 216.312M 634.006M 706.925M 390.341M 442.445M 351.834M 489.399M 320.678M 318.546M 339.244M 336.024M 216.581M 131.358M 129.185M 62.057M 13.55M -3.721M 31.388M 19.295M 33.649M 7.455M 2.061M 4.107M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 194.88 258 191.42 218.5 209.63 246.52 192 122.03 103.58 77.87 63.23 56.37 50.63 45.13 31.2 30.95 60.9 40.71 38.13 41.52 44.52 — — — — — —
Price performance 12m -0.24 0.35 -0.12 0.04 -0.15 0.28 0.57 0.18 0.33 0.23 0.12 0.11 0.12 0.45 0.01 -0.49 0.5 0.07 -0.08 -0.07 — — — — — — —

Filed figures

Figure Jun 2017 Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024 Jun 2025 Jun 2026
Balance sheet detail
Trade receivables (USD) 451M 484M 528M 475M 614M 576M 705M 837M 939M 1.04B
↳ YoY growth +17.9% +7.4% +9.3% -10.2% +29.4% -6.2% +22.4% +18.8% +12.2% +10.3%
↳ 5y CAGR +9.7% +8.7% +8.0% +5.5% +10.0% +5.0% +7.8% +9.6% +14.6% +11.0%
Borrowings, current (USD) — 11.5M 12M 12M 12M 9.92M 9.9M 9.9M 9.9M 260M
Borrowings, non-current (USD) 1.08B — — — — — — — — —
Lease liabilities (USD) — — — 123M 138M 142M 139M 167M 184M 167M
Cash and deposits (USD) 822M 189M 147M 463M 295M 274M 228M 238M 1.21B 1.47B
Intangible assets (USD) 262M 215M 522M 448M 393M 346M 552M 486M 465M 453M
Right-of-use assets (USD) — — — 118M 129M 132M 128M 151M 167M 153M
Net debt (borrowings + leases - cash) (USD) 257M -177M -135M -328M -145M -121M -79.2M -61.7M -1.02B -1.04B
Cash flow detail
Operating cash flow (USD) 414M 505M 459M 802M 737M 351M 693M 1.4B 1.75B 1.81B
Purchases of property, plant and equipment (USD) -62.2M -62.6M -68.7M -95.3M -103M -135M -120M -99.5M -89.9M -156M
Purchases of intangible assets (USD) -9.26M -8.88M -8.63M -10.6M -14.1M -21.2M -14.3M -15.4M -10.8M -2.22M
Change in receivables (cash effect) (USD) -63.6M -32.4M -18M 54.4M -129M 19.3M -107M -134M -76.7M -96.8M
Change in inventories (cash effect) (USD) -41.6M 1.49M -84.2M -69.9M -22M -312M -249M 172M -80.2M -9.92M
Change in payables (cash effect) (USD) 34.6M 201M -27.3M -23.4M 211M -248M 31.3M 122M 91M 173M
Dividends paid (cash effect) (USD) -186M -199M -212M -225M -227M -245M -258M -282M -311M -350M
Share buybacks (cash effect) (USD) — -53.8M -22.8M — — 0.00 0.00 -150M -300M -700M
Interest paid (cash effect) (USD) -28.2M -28.4M -36.2M -40.4M -24M -22.3M -47.4M -45.7M -28.4M -27.1M
Income taxes paid (cash effect) (USD) -92.9M -171M -243M -180M -221M -478M -217M -278M -214M -357M
Share-based compensation (USD) 45.9M 48.4M 52.1M 57.6M 63.9M 65.3M 71.1M 80.2M 91.7M 104M
Operating cash flow before change in receivables (USD) 478M 537M 477M 748M 866M 332M 800M 1.54B 1.83B 1.9B
Free cash flow (OCF - PPE - intangibles) (USD) 343M 434M 382M 696M 620M 195M 559M 1.29B 1.65B 1.65B
Income detail
Research and development expense (USD) 144M 155M 181M 202M 225M 254M 288M 308M 331M 378M
↳ 5y CAGR +5.7% +5.3% +8.8% +11.9% +13.7% +11.9% +13.1% +11.2% +10.4% +10.9%
Total comprehensive income (USD) 376M 280M 376M 591M 565M 660M 938M 1.04B 1.58B 1.52B
Comprehensive income to owners (USD) 376M 280M 376M 591M 565M 660M 938M 1.04B 1.58B 1.52B
Reported Aug 4, 2017 Aug 17, 2018 Aug 8, 2019 Aug 13, 2020 Aug 17, 2021 Aug 9, 2024 Aug 9, 2024 Aug 9, 2024 Aug 8, 2025 Aug 13, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Statement of changes in beneficial ownership Bull 0 Bear 0 Routine
Statement of changes in beneficial ownership Bull 0 Bear 0 Routine

Prompts

ResMed Inc. (ticker RMD), listed in United States.

ETFs Holding ResMed Inc.

ETF Weight in ETF Shares Market value As of
LGHT 9.11% 1,156 $ 225.281K Jun 30, 2026
CWS 4.04% 18,814 $ 4.475M Nov 17, 2026
SEIQ 2.04% 69,334 $ 13.512M Jun 30, 2026
FGSI 1.95% 167 $ 39.835K Nov 11, 2026
RUNN 1.88% 32,577 $ 7.822M Aug 31, 2026
RDVI 1.53% 250,021 $ 59.638M Nov 11, 2026
XOVR 1.36% 152,376 $ 29.695M Jun 30, 2026
QIDX 1.26% 2,325 $ 490.529K Jul 31, 2026
ROE 1.10% 11,464 $ 2.73M Nov 18, 2026
WLTG 1.04% 3,788 $ 799.192K Jul 31, 2026
PY 0.76% 8,575 $ 1.671M Jun 30, 2026
DSTL 0.67% 73,123 $ 14.25M Jun 30, 2026
GQQQ 0.62% 4,283 $ 1.02M Nov 18, 2026
IALT 0.57% 188,884 $ 44.99M Nov 16, 2026
BAMV 0.44% 2,131 $ 511.653K Aug 31, 2026
AVMC 0.36% 8,303 $ 1.978M Nov 16, 2026
PHEQ 0.28% 2,012 $ 392.099K Jun 30, 2026
BDVL 0.26% 19,225 $ 4.579M Nov 16, 2026
JSTC 0.26% 3,246 $ 773.165K Nov 17, 2026
TACU 0.25% 193 $ 45.971K Nov 17, 2026
DFLV 0.23% 73,384 $ 17.531M Nov 12, 2026
DAK 0.22% 384 $ 90K Nov 18, 2026
CLSE short -0.22% -8,122 $ -1.95M Aug 31, 2026
AIVL 0.21% 4,405 $ 858.446K Jun 30, 2026
SOVF 0.20% 838 $ 176.801K Jul 31, 2026
AFLG 0.20% 7,611 $ 1.813M Nov 16, 2026
SFGV 0.19% 9,005 $ 2.14M Nov 18, 2026
TIER 0.14% 225 $ 47.471K Jul 31, 2026
CAPE 0.13% 1,571 $ 306.156K Jun 30, 2026
DFVX 0.12% 3,011 $ 719.298K Nov 12, 2026
GQI 0.12% 1,627 $ 317.07K Jun 30, 2026
AVUQ 0.12% 2,153 $ 512.823K Nov 16, 2026
GSPY 0.12% 3,583 $ 853.435K Nov 17, 2026
DFUV 0.11% 74,325 $ 17.755M Nov 12, 2026
DFSU 0.11% 10,903 $ 2.605M Nov 12, 2026
GVLU 0.09% 1,038 $ 247.241K Nov 17, 2026
XMAG 0.08% 684 $ 163.401K Nov 13, 2026
THEQ 0.07% 112 $ 26.677K Nov 17, 2026
VSLU 0.06% 1,699 $ 331.101K Jun 30, 2026
MODL 0.06% 3,168 $ 617.38K Jun 30, 2026
DFAU 0.06% 30,974 $ 7.399M Nov 12, 2026
DXUV 0.06% 14,494 $ 3.462M Nov 12, 2026
FLSP 0.05% 2,535 $ 494.021K Jun 30, 2026
AVLC 0.05% 3,348 $ 797.46K Nov 16, 2026
DFAC 0.05% 182,205 $ 43.527M Nov 12, 2026
DFUS 0.05% 43,821 $ 10.468M Nov 12, 2026
DCOR 0.04% 83,956 $ 20.056M Nov 12, 2026
VOXP 0.04% 12 $ 2,531.76 Jul 31, 2026
GDE 0.04% 849 $ 203.845K Aug 31, 2026
AVUS 0.04% 26,148 $ 6.228M Nov 16, 2026
AVSU 0.04% 804 $ 191.505K Nov 16, 2026
APUE 0.04% 4,009 $ 962.561K Aug 31, 2026
HCMT 0.04% 1,007 $ 212.457K Jul 31, 2026
NTSX 0.04% 2,529 $ 492.852K Jun 30, 2026
MSLC 0.03% 5,633 $ 1.352M Aug 31, 2026
ACVF 0.03% 230 $ 48.525K Jul 31, 2026
NTSD 0.02% 40 $ 7,795.20 Jun 30, 2026
CSHP 0.02% 291 $ 69.313K Nov 16, 2026
EBI 0.01% 159 $ 38.176K Aug 31, 2026
CORO 0.00% 91 $ 21.67K Nov 16, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
RMD canonical Common share — US nyse 237.00 USD 2026-11-17
RMD Common share — AU asx — —